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     INTRODUCTION 
  Malaria kills approximately one million persons each year, 
and the major burden of morbidity and mortality is in children 
less than five years of age, especially in sub-Saharan Africa.  1  
  Plasmodium falciparum   is the main cause of malaria. The dis-
ease has the most profound economic impact in developing 
countries, where it is estimated that 12 billion dollars per year 
are lost in cost of care and reduced productivity.  2  
  Chloroquine and sulfadoxine-pyrimethamine have been the 
traditional drugs used for treatment of patients with malaria. 
However, increasing resistance of   P. falciparum   in many 
countries has prompted calls for changes to this approach. 
Current recommendations from the World Health Organiza-
tion (WHO) are for artemisinin-based combination therapy 
(ACT) as the first-line regimen for patients with uncompli-
cated malaria.  3   However, ACT is significantly more expensive 
than the older anti-malarial drugs, costing up to 10 times the 
price of the chloroquine.  4  
  The Global Fund to Fight AIDS, Tuberculosis, and Malaria 
has pledged to assist poor countries with the cost of ACT. 
Nevertheless, resources are inevitably limited. The true cost-
benefit, and thus viability of the ACT approach, will hinge 
partly on the ability to accurately diagnose malaria. Frequent 
false-positive results would result in unnecessary administra-
tion of the more expensive ACT, and perhaps undue adverse 
effects, and false-negative results would result in delayed treat-
ment, driving up costs and increasing morbidity and mortality. 
  Laboratory diagnosis of malaria is most frequently made by 
microscopy, but the sensitivity and specificity of this modal-
ity varies greatly with the experience and skill of the micros-
copist.  5   Furthermore, microscopes are beyond the financial 
means of many healthcare facilities, especially in rural areas 
of sub-Saharan Africa. There are commercially available rapid 
tests for malaria that are sensitive, specific, and easy to use, 
but their expense again precludes widespread use.  6   Most rural 
health centers therefore rely on syndromic diagnosis. However, 
the typically non-specific presenting signs and symptoms of 
malaria make this difficult.  7  
  Various algorithms have been developed to facilitate syn-
dromic diagnosis of malaria by healthcare workers in resource-
poor settings. The WHO program for Integrated Management 
of Childhood Illness (IMCI) provides guidelines on how chil-
dren in resource limited settings should be evaluated and 
treated.  8   The World Health Organization recommends that 
these guidelines may be adapted to suit local health care sys-
tems. According to IMCI guidelines, one of the first steps in 
evaluating a child with fever is to determine the local risk of 
malaria. A place is considered high risk for malaria if > 5% 
of fevers among children is caused by malaria. A child with 
fever in a high-risk area who does not appear to have measles 
based on physical examination should be classified as having 
malaria. These children should receive anti-malarial drugs in 
addition to any other treatments that are deemed necessary 
based on results of a physical examination. 
  Sierra Leone is a country on the west coast of Africa and has 
six million inhabitants. The 12-year civil war in Sierra Leone, 
which ended in 2002, decimated the nation’s economy and 
infrastructure, including its public health system. The disease 
is the number one cause of morbidity and mortality in this 
country and is responsible for up to 48% of visits to health-
care workers.  9   The high prevalence of chloroquine resistance 
in Sierra Leone (up to 79% of malaria cases) has led the coun-
try to officially adopt ACT as the treatment of choice in accor-
dance with WHO guidelines, but the financial implications of 
this policy and the burden imposed on the country’s recov-
ering public health system have not been fully explored.  9–  11  
Recognizing the key role that accurate diagnosis plays in 
determining the cost-benefit of ACT as a first-line therapy for 
malaria, we conducted a pilot study to assess the accuracy of 
syndromic diagnosis for malaria in children made by health-
care workers in rural Sierra Leone and to determine what 
additional factors could be incorporated into the IMCI guide-
lines to improve malaria diagnosis. Sierra Leone is classified as 
a high-risk malaria area, which means that children less than 
five years of age who have fever in the absence of any signs 
of measles are treated with anti-malarial drugs according to 
IMCI guidelines. To date, there are no country-specific modifi-
cations of the IMCI guidelines for Sierra Leone.  8  
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   METHODS 
    Study site and population.     The research protocol was 
reviewed and approved by the Ethics Committee of the Sierra 
Leone Ministry of Health and Sanitation, the Institutional 
Review Board of Tulane University, and the District Medical 
Officer in Bo District. The study was conducted in the Bo 
District of Sierra Leone, where the Medical Research Center 
is located and has extensive experience. Three rural healthcare 
centers in Bo (Dambala, Njala Komboya, and Baomahun) 
known as peripheral health units (PHUs) were selected for 
study based on accessibility and adequate numbers of patients. 
Each of these PHUs is headed by a community health officer 
(CHO) trained in the delivery of basic primary healthcare. In 
2005, CHOs typically made a diagnosis of malaria based on 
the presenting signs and symptoms (i.e., syndromic diagnosis) 
because microscopy or rapid tests were not available in the 
PHUs (although their availability has recently been increasing). 
All children two months to five years of age who came to one 
of these three PHUs for medical attention in July and August 
(rainy season) 2005 were eligible for enrollment in the study. 
   Questionnaire  and  laboratory  analysis.    After  seeing  each 
eligible child, the CHO was requested to complete a brief 
questionnaire for demographic information on the child, 
presenting signs and symptoms, use of bed nets, and the 
diagnosis the CHO ultimately made. The IMCI weight-for-age 
chart was used; Z scores < −2 indicating low weight and scores 
< −3 indicating very low weight.  8   The CHOs were blinded to 
the purpose of the study to prevent influencing their diagnosis 
or management of the patients. After the questionnaire was 
completed, it was reviewed independently by a member of the 
research team. If a diagnosis of malaria was made by the CHO, 
informed consent was obtained from the parent or guardian 
and the child was enrolled in the study. Blood was obtained 
and tested for   P. falciparum   by using the Paracheck-Pf rapid 
test (Orchid Biomedical Systems, Goa, India), which has 
been reported to be 97% sensitive and 88% specific for this 
parasite.  12   Children who did not receive a clinical diagnosis of 
malaria from the CHO were not enrolled. 
   Data  collection  and  analysis.     Data on the questionnaire 
were entered into an Excel spreadsheet (Microsoft, Redmond, 
WA) and imported into the SAS 9.1 software package (SAS 
Institute Inc., Cary, NC) for analysis. Two-by-two contingency 
tables were used to generate crude estimates of association 
between the factors noted in the questionnaire and the results 
of the Paracheck test, which was considered the gold standard 
of malaria diagnosis for the study. Factors with a   P   values  ≤ 0.4 
level were further explored by using a multivariable logistic 
regression model. All tests of hypothesis were two-tailed with 
a type 1 error rate set at 5%. 
    RESULTS 
  One hundred seventy-five children were considered to 
have malaria by the CHOs at the three PHUs based on the 
syndromic diagnosis and were enrolled in the study: 63 from 
Dambala, 44 from Njala Komboya, and 68 from Baomahun 
(  Table 1  ). The positive predictive value (PPR) of syndromic 
diagnosis of malaria was 82%. A significantly lower percentage 
of the syndromic malaria cases were positive by the Paracheck 
test in Baomahun than in Dambala (  P   = 0.006). Otherwise, 
there were no significant differences between the PHUs with 
regard to any demographic variable or Paracheck test result 
(  Table 1  ). Therefore, aggregated data from all three PHUs are 
presented. 
            The results of univariate analysis of the relationship of vari-
ous demographic and behavioral factors and clinical signs and 
symptoms with a laboratory-confirmed diagnosis of malaria 
are shown in   Table 2  . Palmar pallor (  P   = 0.01) and splenom-
egaly (  P   = 0.001) were significantly associated with a diagnosis 
of malaria. Sleeping under a bed net was of borderline statisti-
cal significance (  P   = 0.07). 
            The results of the multivariate analysis are shown in   Table 3  . 
After controlling for other variables, children with splenom-
egaly were three times more likely to have malaria (  P   = 0.04), 
and those who reported sleeping under bed nets were 70% 
less likely (  P   = 0.05). Malaria was 13 times more likely in 
children with fever, but this relationship was not statistically 
significant (  P   = 0.09). 
        DISCUSSION 
  We assessed the quality of syndromic malaria diagnosis in 
rural Sierra Leone and identified factors that may enhance 
its accuracy. The CHOs in the study provided a diagnosis of 
malaria with a reasonably high PPV of 82%. This finding sug-
gests that assuming that the drugs are accessible, most chil-
dren who come to a PHU and are considered to have malaria 
on syndromic grounds would receive ACT, which is favorable 
in terms of limiting morbidity and mortality. There was sig-
nificant variation (72–92%) by PHU in the accuracy of the 
malaria diagnosis made, which could indicate varied clini-
cal skills of the respective CHOs or different baseline inci-
dences of malaria in the catchment areas of the PHUs because 
PPV is influenced by the baseline frequency of the disease of 
interest. 
  We can only speculate as to what other clinical observations 
were deemed important by the CHOs in assigning a diagno-
sis of malaria, but it is entirely possible that splenomegaly, a 
frequent manifestation that was significantly associated with 
the disease in our study, was one factor that was considered. 
Interestingly, our data suggest that consideration of the back-
ground risk of malaria transmission, in addition to direct clin-
ical observations, can help in the diagnosis because the use 
of bed nets was shown to be protective.  13,  14   This finding also 
 Table 1 
    Demographic information and Paracheck-Pf results on 175 children 
suspected to have malaria based on syndromic diagnosis, Sierra 
Leone  
Variable
No. (%) enrolled 
(n = 175)
Paracheck test result
No. (%) positive 
(n = 143)
No. (%) negative 
(n = 32)
Peripheral health unit
Dambala  *  63 (36) 58 (92) 5 (8)
Njala Komboya 44 (25) 36 (82) 8 (16)
Baomahun  *  68 (39) 49 (72) 19 (28)
All 175 (100) 143 (82) 32 (18)
Age, months
< 12 88 (50) 74 (84) 14 (16)
³ 12 87 (50) 69 (79) 18 (21)
Sex † 
Male 82 (48) 70 (85) 12 (15)
Female 89 (52) 71 (80) 18 (20)
  *     P   = 0.006 for Dambala versus Boamahun.   
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highlights the need for continued distribution and use of bed 
nets. Despite their demonstrated protective effect, they were 
used by only 12% of the children we surveyed. 
  The major shortcoming of our study is that logistical lim-
itations prevented us from including children who did not 
receive a syndromic diagnosis of malaria. Thus, we cannot 
calculate the sensitivity, specificity, or negative predictive val-
ues of the CHOs diagnoses. A high PPV and sensitivity with 
a syndromic diagnosis approach could easily be achieved by 
assuming that most febrile illnesses are malaria, at the cost 
of a poor specificity and negative predictive value. Although 
the assumption that fever equals malaria might be consid-
ered reasonable in countries such as Sierra Leone, where 
malaria is endemic, recent findings suggest that malaria may 
be over-diagnosed even in areas of frequent transmission.  15  
Furthermore, although this approach might be favorable in 
terms of limiting morbidity and mortality because all chil-
dren with malaria would be treated, it would be expensive and 
perhaps unsustainable because ACT would be given to many 
children who, in fact, would not have the disease. The assump-
tion of malaria would also likely result in delayed recognition 
and treatment of other diseases. Lastly, the overly liberal use 
of ACT might promote the development of artemisinin resis-
tance. Drug failure of   P. falciparum   to artemisinin compounds 
has already been reported in Sierra Leone.  16  
  Other limitations of our study include the relatively small 
sample size and non-random selection of the PHUs, which 
dictate caution in generalizing our findings to other areas of 
Sierra Leone or other countries and our inability to deter-
mine precisely which factors were used by the CHOs to make 
a diagnosis of malaria. We cannot conclude that the experi-
ence and skills of the CHOs in this study are the normal situ-
ation in Sierra Leone, although there is no particular reason 
to believe that they are not representative. Lastly, because the 
Paracheck test detects only   P. falciparum  , it is possible that 
cases of malaria caused by   P. malariae   or   P. ovale   were  missed, 
although these parasites account for a small proportion of 
malaria in Sierra Leone.  17,  18  
  In summary, data from this pilot study show that the PPV of 
syndromic diagnosis for malaria in Sierra Leone is reasonably 
high, and it might be further improved by including questions 
about bed net use and emphasizing the importance of a thor-
ough evaluation for splenomegaly in the evaluation of fever 
among children. Consideration should be given to including 
these measures in the Sierra Leone National IMCI guide-
lines. Future studies should include children thought to have 
malaria and other diagnoses to determine the sensitivity, spec-
ificity, and negative predictive values for syndromic malaria 
diagnosis. Furthermore, a larger number of PHUs and CHOs 
ideally distributed around the country should be studied to 
better assess inter-observer and inter-regional variability in 
Sierra Leone. 
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 Table 2 
    Univariate analysis of factors associated with malaria diagnosis as 
determined by the Paracheck-Pf rapid test, Sierra Leone   
Variable
Paracheck test, 
no. (%) positive 
(n = 143)
Paracheck test, 
no. (%) negative 
(n = 32)
Crude odds ratio 
(95% confidence 
interval)   P 
Age, months
< 12 74 (84) 14 (16) 1.0 0.4
³ 12 69 (79) 18 (21) 0.7 (0.3–1.6)
Sex * 
Female 70 (85) 12 (15) 1.0 0.4
Male 71 (80) 18 (20) 0.7 (0.3–1.5)
Weight-for-age
Normal 79 (57) 17 (57) 1.0 0.8
Very low 34 (24) 6 (20) 1.2 (0.4–3.4)
Sleeps under bed net
No 122 (88) 22 (76) 1.0 0.07
Yes 16 (12) 7 (24) 0.4 (0.2–1.1)
Fever † 
No 1 (1) 1 (3) 1.0 0.2
Yes 142 (99) 31 (97) 4.6 (0.3–75.2)
Palmar pallor
No 96 (68) 28 (90) 1.0 0.01
Yes 46 (32) 3 (10) 4.5 (1.3–13.5)
Splenomegaly
No 68 (50) 23 (82) 1.0 0.001
Yes 68 (50) 5 (18) 4.6 (1.6–12.8)
Lethargy
No 127 (89) 30 (97) 1.0 0.2
Yes 16 (11) 1 (3) 3.8 (0.5–29.6)
Cough
No 27 (19) 3 (9) 1.0 0.2
Yes 116 (81) 29 (91) 0.4 (0.1–1.6)
Vomiting
No 80 (56) 18 (58) 1.0 0.9
Yes 62 (44) 13 (42) 1.1 (0.5–2.4)
Diarrhea
No 130 (91) 29 (94) 1.0 0.6
Yes 13 (9) 2 (6) 1.4 (0.3–6.8)
Poor feeding
No 90 (63) 17 (55) 1.0 0.4
Yes 53 (37) 14 (45) 0.7 (0.3–1.6)
    *     Sex data were missing for four patients.   
    †     Refers to a subjective feeling of fever as reported by the patients and/or the community 
health officer’s impression through touching and observing the patient. Temperatures were 
not consistently taken at all peripheral health units.   
 Table 3 
    Multivariate analysis of factors associated with malaria diagnosis as 
determined by the Paracheck-Pf rapid test, Sierra Leone   
Variable Odds ratio (95% confidence interval)   P 
Age, months
< 12 1.0 0.55
³ 12 0.7 (0.3–2.0)
Sleeps under bed net
No 1.0 0.05
Yes 0.3 (0.1–0.98)
Fever * 
No 1.0 0.09
Yes 13.3 (0.7–263.4)
Palmar pallor
No 1.0 0.16
Yes 2.8 (0.6–12.1)
Splenomegaly
No 1.0 0.04
Yes 3.2 (1.02–10.1)
Lethargy
No 1.0 0.55
Yes 2.0 (0.2–17.2)
Cough
No 1.0 0.27
Yes 0.4 (0.1–1.8)
    *     Refers to a subjective feeling of fever as reported by the patients. Temperatures were not 
consistently taken at all peripheral health units.   528 NNEDU AND OTHERS
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